ArticleBiomedical reports2016

Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy.

Masahiko Sumitani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.